Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Novel therapeutic options for management of electrolyte disorders.

Shah A, Navaneethan SD.

Curr Opin Nephrol Hypertens. 2019 Jun 20. doi: 10.1097/MNH.0000000000000523. [Epub ahead of print] No abstract available.

PMID:
31232711
2.

Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.

Ali S, Dave N, Virani SS, Navaneethan SD.

Curr Atheroscler Rep. 2019 Jun 22;21(9):32. doi: 10.1007/s11883-019-0794-6. Review.

PMID:
31230129
3.

Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis.

Navaneethan SD, Shao J, Buysse J, Bushinsky DA.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1011-1020. doi: 10.2215/CJN.13091118. Epub 2019 Jun 13.

PMID:
31196951
4.

Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes.

Walther CP, Winkelmayer WC, Niu J, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD.

Am J Kidney Dis. 2019 May 31. pii: S0272-6386(19)30704-8. doi: 10.1053/j.ajkd.2019.03.423. [Epub ahead of print]

PMID:
31160142
5.

Predialysis Nephrology Care and Incident Atrial Fibrillation in Older Patients With ESKD Initiating Dialysis.

Anumudu S, Airy M, Erickson KF, Navaneethan SD, Chang TI, Winkelmayer WC, Niu J.

Kidney Int Rep. 2019 Feb 13;4(5):679-687. doi: 10.1016/j.ekir.2019.02.007. eCollection 2019 May.

6.

Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease.

Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY.

J Am Heart Assoc. 2019 Feb 5;8(3):e009980. doi: 10.1161/JAHA.118.009980.

7.

Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss.

Navaneethan SD.

Circulation. 2019 Jan 15;139(3):376-379. doi: 10.1161/CIRCULATIONAHA.118.038677. No abstract available.

PMID:
30640548
8.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

9.

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Navaneethan SD, Akeroyd JM, Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Ballantyne C, Winkelmayer WC, Ramanathan V, Virani SS.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1842-1850. doi: 10.2215/CJN.03830318. Epub 2018 Nov 29.

PMID:
30498000
10.

Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).

Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V.

Am J Nephrol. 2018;48(6):472-481. doi: 10.1159/000495081. Epub 2018 Nov 23.

PMID:
30472701
11.

What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry.

Saeed F, Arrigain S, Schold JD, Nally JV Jr, Navaneethan SD.

Nephron. 2019;141(2):98-104. doi: 10.1159/000494298. Epub 2018 Nov 21. Review.

PMID:
30463082
12.

Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.

Niu J, Shah MK, Perez JJ, Airy M, Navaneethan SD, Turakhia MP, Chang TI, Winkelmayer WC.

Am J Kidney Dis. 2019 Mar;73(3):324-331. doi: 10.1053/j.ajkd.2018.09.011. Epub 2018 Nov 16.

PMID:
30449517
13.

Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure Control.

Walther CP, Shah M, Navaneethan SD.

Am J Kidney Dis. 2019 Jan;73(1):4-7. doi: 10.1053/j.ajkd.2018.09.008. Epub 2018 Nov 10. No abstract available.

PMID:
30424915
14.

Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Bansal N, Xie D, Sha D, Appel LJ, Deo R, Feldman HI, He J, Jamerson K, Kusek JW, Messe S, Navaneethan SD, Rahman M, Ricardo AC, Soliman EZ, Townsend R, Go AS.

J Am Soc Nephrol. 2018 Dec;29(12):2859-2869. doi: 10.1681/ASN.2018050514. Epub 2018 Oct 30.

PMID:
30377231
15.

Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.

Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV Jr, Nakhoul GN.

Nephron. 2019;141(1):31-40. doi: 10.1159/000494047. Epub 2018 Oct 26.

PMID:
30368506
16.

Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.

Vangala C, Niu J, Lenihan CR, Mitch WE, Navaneethan SD, Winkelmayer WC.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1534-1541. doi: 10.2215/CJN.02190218. Epub 2018 Sep 27.

PMID:
30262672
17.

Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.

Shurrab M, Ko DT, Zayed Y, Navaneethan SD, Yadak N, Yaseen A, Kaoutskaia A, Qamhia W, Hamdan Z, Haj-Yahia S, Lee DS, Newman D, Healey JS, Harvey P, Crystal E.

J Interv Card Electrophysiol. 2018 Oct;53(1):123-129. doi: 10.1007/s10840-018-0424-1. Epub 2018 Jul 30. Review.

PMID:
30058056
18.

Association between intensity of statin therapy and mortality in persons with chronic kidney disease.

Walther CP, Richardson PA, Virani SS, Winkelmayer WC, Navaneethan SD.

Nephrol Dial Transplant. 2018 Jul 20. doi: 10.1093/ndt/gfy237. [Epub ahead of print]

PMID:
30053252
19.

Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.

Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV Jr, Navaneethan SD.

Am J Nephrol. 2018;48(1):36-45. doi: 10.1159/000491023. Epub 2018 Jul 26.

PMID:
30048961
20.

Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease.

Walther CP, Niu J, Winkelmayer WC, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD.

J Am Heart Assoc. 2018 Jul 6;7(14). pii: e008664. doi: 10.1161/JAHA.118.008664.

21.

Emerging therapeutic options for management of anaemia in with patients with chronic kidney disease.

Ali S, Dave N, Navaneethan SD.

Curr Opin Nephrol Hypertens. 2018 Sep;27(5):329-330. doi: 10.1097/MNH.0000000000000434. No abstract available.

PMID:
29939850
22.

Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.

Bansal N, Roy J, Chen HY, Deo R, Dobre M, Fischer MJ, Foster E, Go AS, He J, Keane MG, Kusek JW, Mohler E, Navaneethan SD, Rahman M, Hsu CY; CRIC Study Investigators.

Am J Kidney Dis. 2018 Sep;72(3):390-399. doi: 10.1053/j.ajkd.2018.02.363. Epub 2018 May 18.

PMID:
29784617
23.

Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD.

Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD.

Am J Kidney Dis. 2018 Oct;72(4):620-622. doi: 10.1053/j.ajkd.2018.03.020. Epub 2018 May 18. No abstract available.

PMID:
29784611
24.

Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease.

Navaneethan SD, Mandayam S.

Kidney Int Rep. 2017 Dec 26;3(2):244-246. doi: 10.1016/j.ekir.2017.12.010. eCollection 2018 Mar. No abstract available.

25.

High-density lipoprotein cholesterol and causes of death in chronic kidney disease.

Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV Jr.

J Clin Lipidol. 2018 Jul - Aug;12(4):1061-1071.e7. doi: 10.1016/j.jacl.2018.03.085. Epub 2018 Mar 30.

26.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J.

Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29. Erratum in: Kidney Int. 2018 Nov;94(5):1025-1026.

27.

Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.

Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY; CRIC Study Investigators.

Am J Kidney Dis. 2018 May;71(5):657-665. doi: 10.1053/j.ajkd.2017.09.015. Epub 2017 Dec 6.

28.

Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis.

Airy M, Chang TI, Ding VY, Goldstein BA, Bansal N, Niu J, Navaneethan SD, Turakhia MP, Winkelmayer WC.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1590-1597. doi: 10.1093/ndt/gfx301.

PMID:
29145634
29.

Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease.

Qureshi S, Lorch R, Navaneethan SD.

Curr Hypertens Rep. 2017 Oct 18;19(11):92. doi: 10.1007/s11906-017-0790-6. Review.

PMID:
29046987
30.

Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.

Walther CP, Chandra A, Navaneethan SD.

Curr Opin Nephrol Hypertens. 2018 Jan;27(1):16-22. doi: 10.1097/MNH.0000000000000375. Review.

31.

Impact of Uric Acid Levels on Kidney Disease Progression.

Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV Jr, Rothberg MB.

Am J Nephrol. 2017;46(4):315-322. doi: 10.1159/000481460. Epub 2017 Oct 13.

PMID:
29032376
32.

Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.

Rehman H, Akeroyd JM, Ramsey D, Ahmed ST, Merchant AT, Navaneethan SD, Petersen LA, Virani SS.

Clin Cardiol. 2017 Nov;40(11):1055-1060. doi: 10.1002/clc.22769. Epub 2017 Aug 25.

33.

Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.

Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1418-1427. doi: 10.2215/CJN.02100217. Epub 2017 Aug 4.

34.

Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV Jr.

Kidney Int. 2017 Nov;92(5):1272-1281. doi: 10.1016/j.kint.2017.04.030. Epub 2017 Jul 24.

35.

Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk.

Navaneethan SD, Virani SS.

J Am Heart Assoc. 2017 Jul 14;6(7). pii: e006020. doi: 10.1161/JAHA.117.006020. No abstract available.

36.

Emerging therapeutic options for managing diabetic kidney disease.

Walther CP, Whaley-Connell A, Navaneethan SD.

Curr Opin Nephrol Hypertens. 2017 Sep;26(5):335-337. doi: 10.1097/MNH.0000000000000345. No abstract available.

PMID:
28548994
37.

Statin use and hip fractures in U.S. kidney transplant recipients.

Vangala C, Lenihan CR, Montez-Rath ME, Nair SS, Navaneethan SD, Ramanathan V, Winkelmayer WC.

BMC Nephrol. 2017 May 1;18(1):145. doi: 10.1186/s12882-017-0559-9.

38.

Bariatric Surgery and Kidney-Related Outcomes.

Chang AR, Grams ME, Navaneethan SD.

Kidney Int Rep. 2017 Mar;2(2):261-270. doi: 10.1016/j.ekir.2017.01.010. Epub 2017 Jan 26.

39.

Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease.

Kalantar-Zadeh K, Crowley ST, Beddhu S, Chen JLT, Daugirdas JT, Goldfarb DS, Jin A, Kovesdy CP, Leehey DJ, Moradi H, Navaneethan SD, Norris KC, Obi Y, O'Hare A, Shafi T, Streja E, Unruh ML, Vachharajani TJ, Weisbord S, Rhee CM.

Semin Dial. 2017 May;30(3):251-261. doi: 10.1111/sdi.12601. Epub 2017 Apr 18. Review.

40.

Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR; STAMPEDE Investigators.

N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869.

41.

Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr.

Am J Kidney Dis. 2017 Aug;70(2):191-198. doi: 10.1053/j.ajkd.2016.11.018. Epub 2017 Feb 10.

42.

Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.

Chirakarnjanakorn S, Navaneethan SD, Francis GS, Tang WH.

Int J Cardiol. 2017 Apr 1;232:12-23. doi: 10.1016/j.ijcard.2017.01.015. Epub 2017 Jan 4. Review.

43.

Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease.

Walther CP, Navaneethan SD.

J Am Soc Nephrol. 2017 Mar;28(3):723-725. doi: 10.1681/ASN.2016111173. Epub 2017 Jan 3. No abstract available.

44.

A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial.

Kirwan JP, Malin SK, Scelsi AR, Kullman EL, Navaneethan SD, Pagadala MR, Haus JM, Filion J, Godin JP, Kochhar S, Ross AB.

J Nutr. 2016 Nov;146(11):2244-2251. Epub 2016 Oct 19.

45.

Phosphate Binders: The Evidence Gap Persists.

Airy M, Winkelmayer WC, Navaneethan SD.

Am J Kidney Dis. 2016 Nov;68(5):667-670. doi: 10.1053/j.ajkd.2016.08.008. No abstract available.

PMID:
27772629
46.

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

JAMA Cardiol. 2016 Aug 1;1(5):548-56. doi: 10.1001/jamacardio.2016.1445.

47.

Copeptin and Decline in Kidney Function.

Yan J, Navaneethan SD.

Am J Nephrol. 2016;44(1):19-21. doi: 10.1159/000447369. Epub 2016 Jun 28. No abstract available.

48.

Bariatric surgery for obesity-associated decline in kidney function: filling the knowledge gap?

Agrawal V, Navaneethan SD.

Kidney Int. 2016 Jul;90(1):28-30. doi: 10.1016/j.kint.2016.03.029.

PMID:
27312446
49.

Pragmatic Clinical Trials in CKD: Opportunities and Challenges.

de Boer IH, Kovesdy CP, Navaneethan SD, Peralta CA, Tuot DS, Vazquez MA, Crews DC; American Society of Nephrology Chronic Kidney Disease Advisory Group.

J Am Soc Nephrol. 2016 Oct;27(10):2948-2954. Epub 2016 Jun 9. Review.

50.

Interventions for lowering plasma homocysteine levels in dialysis patients.

Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ.

Cochrane Database Syst Rev. 2016 May 31;(5):CD004683. doi: 10.1002/14651858.CD004683.pub4. Review.

PMID:
27243372

Supplemental Content

Loading ...
Support Center